DYN: 戴纳基

DYN新闻

• 12:05 周五盘前交易时段中波动的12只医疗保健股
• 12:05 12 Health Care Stocks Moving In Friday's Pre-Market Session
• 10:18 HC Wainwright & Co. Maintains Buy on Dyne Therapeutics, Lowers Price Target to $32
• 20:10 Dyne Therapeutics 仍预计将于 2027 年第一季度公布 Achieve REC 的顶线数据，该研究的主要终点为 6 个月时 vHOT 较基线的变化，旨在支持其于 2027 年第三季度向美国提交潜在的加速批准申请
• 20:10 Dyne Therapeutics Continues To Expect Topline Data In Q1 2027 From The Achieve REC, With A Primary Endpoint Of Change From Baseline In vHOT At 6 Months, Intended To Support A Potential Submission For U.S. Accelerated Approval In Q3 2027
• 20:08 Dyne Therapeutics公布了来自1/2期ACHIEVE试验的额外一年临床数据
• 20:08 Dyne Therapeutics Announces Additional One-Year Clinical Data From Phase 1/2 ACHIEVE Trial
• 17:46 Piper Sandler Reiterates Overweight on Dyne Therapeutics, Maintains $47 Price Target
• 20:39 Stocks Fall as Crude Prices Soar and Bond Yields Climb
• 14:20 Stocks Pressured as Inflation Fears Boost Bond Yields
• 11:45 Dyne Therapeutics Remains A Buy Even As Novartis Trial Failure Hits DM1 Class (NASDAQ:DYN)
• 20:32 Stocks Settle Lower on Middle East Jitters
• 12:01 Novartis, Ionis Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session - Baidu